New Edge Wealth, LLC Abbott Laboratories Transaction History

New Edge Wealth, LLC

$5.41 Billion
Q3 2024

A detailed history of New Edge Wealth, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, New Edge Wealth, LLC holds 39,374 shares of ABT stock, worth $4.46 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

39,374

Previous 29,248 34.62%

Holding current value

$4.46 Million

Previous $3.04 Million 47.71%

% of portfolio

0.08%

Previous 0.07%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $1.01 Million - $1.2 Million	10,126 Added 34.62%	39,374 $4.49 Million
Q2 2024 Aug 01, 2024	SELL	$100.73 - $112.44 $302,592 - $337,769	-3,004 Reduced 9.31%	29,248 $3.04 Million
Q1 2024 May 06, 2024	SELL	$109.52 - $120.96 $93,311 - $103,057	-852 Reduced 2.57%	32,252 $3.67 Million
Q4 2023 Jan 29, 2024	BUY	$90.19 - $110.4 $34,362 - $42,062	381 Added 1.16%	33,104 $3.64 Million
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $3.82 Million - $4.59 Million	-40,036 Reduced 55.03%	32,723 $3.17 Million
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $2.94 Million - $3.27 Million	29,154 Added 66.86%	72,759 $7.93 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $278,181 - $327,436	-2,872 Reduced 6.18%	43,605 $4.42 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $220,349 - $258,503	2,318 Added 5.25%	46,477 $5.1 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $487,380 - $564,295	5,037 Added 12.88%	44,159 $4.27 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $2.42 Million - $2.92 Million	23,708 Added 153.81%	39,122 $4.25 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $1.76 Million - $2.14 Million	15,414 New	15,414 $1.82 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.

Account

New Edge Wealth, LLC Abbott Laboratories Transaction History